首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠心病血瘀证患者血浆和单核细胞水平凝血/纤溶活性研究
引用本文:吕中,施赛珠.冠心病血瘀证患者血浆和单核细胞水平凝血/纤溶活性研究[J].中国中西医结合杂志,2000,20(6):418-420.
作者姓名:吕中  施赛珠
作者单位:[1]浙江中医学院附属第二医院,杭州 [2]上海医科大学附属华山医院,杭州
摘    要:目的:研究并比较冠心病血瘀证患者血浆和单核细胞水平凝血/纤溶活性的改变及其意义。方法:80例冠心病患者分为血瘀证组30例和非血瘀证组50例(包括痰浊型27例,气滞型28例),另设健康对照组20名;采用发色底物法分别检测血浆和外周血单核细胞(PBMC)组织型纤溶酶原激活物(t-PA)及其抑制物(PAI-1)活性,并检测PBMC促凝活性(PCA)。结果:冠心病血瘀证患者血浆PAI-1活性和PBMCPC

关 键 词:冠心病  血瘀证  单核细胞  血浆  凝血/纤溶活性

Study on Blood Coagulant/Fibrinolytic Activity at Plasma and Monocytic Levels in Coronary Heart Disease Patients with Blood-Stasis Syndrome of Traditional Chinese Medicine
Authors:LU Zhong  SHI Saizhu
Institution:Second Affiliated Hospital of Zhejiang College of TCM, Hangzhou (310007).
Abstract:Objective: To explore and compare the changes of coagulant/fibrinolytic activity in coronary heart disease (CHD) patients with Blood Stasis Syndrome of TCM and evaluate the roles of these changes. Methods: Eighty patients of CHD were divided into two groups by Syndrome Differentiation of TCM, the Blood-Stasis (BS) group (30 cases) and the non-Blood-Stasis (NBS) group (50 cases, including 27 cases of Phlegm-Dampness Syndrome and 23 cases of Q1-Stagnation Syndrome); and 20 healthy persons were enrolled as normal control group. Tissue type plasminogen activator (t-PA) and its inhibitor (PAI-1) in pIasma and in human peripheral blood monocyte cell (PBMC), as well as the procoagulant activity (PCA) in PBMC were measured by chro mogenic substrate method. Results: The plasma PAI-1 activity and PCA of PBMC in the BS group were signifi cantly higher than those in the NBS group and the normal control group (P < 0. 01). PAI-1 activity of PBMC in the two groups of CHD patients was higher than those in the normal control group significantly (P < 0. 01), but no significant difference was found between the BS group and the NBS group (P > 0. 05). The difference of plasma t-PA activity between the two groups of CHD was insignificant. The PBMC t-PA activity in the BS group was lower than that in the NBS and normal control groups (P < 0. 01 ). Conclusion: In the CHD patients with BS, the PBMC PCA was increased and the fibrinolytic activity at both plasma and monocyte levels lowered significantly, these changes in coagulant/fibrinolytic activity may be the important pathologic factors in forming BS which suggests that CHD patients with BS were in the prothrombotic state.
Keywords:coronary heart disease with Blood-Stasis Syndrome    plasma  monocyte  blood coagulation/ fibrinolytic activity
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号